Porsche cuts full-year sales outlook-February 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Porsche cuts full-year sales outlook

May 25, 2025 8:16 PM

April 28 (Reuters) - German sports car maker Porsche

said on Monday it has cut its full-year sales

outlook to a range of 37 billion euros ($42.24 billion) to 38

billion euros.

($1 = 0.8759 euros)

Previous page： Stereotaxis Says Magic Sweep Catheter Receives US FDA Clearance; Shares Up Pre-Bell Next page： E. W. Scripps Launches Private Offering of $650 Million of Senior Notes

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Stereotaxis Says Magic Sweep Catheter Receives US FDA Clearance; Shares Up Pre-Bell

Jul 28, 2025

08:23 AM EDT, 07/28/2025 (MT Newswires) -- Stereotaxis ( STXS ) said Monday its Magic Sweep catheter has received US Food and Drug Administration 510(k) clearance. The 20-electrode Magic Sweep is an electrophysiology mapping catheter for the diagnosis and treatment of arrhythmia patients, the company said. Stereotaxis ( STXS ) shares were up 17% in recent premarket activity. ...

E. W. Scripps Launches Private Offering of $650 Million of Senior Notes

Jul 28, 2025

08:26 AM EDT, 07/28/2025 (MT Newswires) -- E. W. Scripps ( SSP ) said Monday it launched a private offering of $650 million of new senior secured second-lien notes expected to mature in 2030. The company said it plans to use the net proceeds to pay the fees and expenses related to the transaction, redeem all of its outstanding 5.875%...

Alterity Therapeutics Says ATH434 Conferred Clinical Benefit in Phase 2 Trial for Multiple System Atrophy

Jul 28, 2025

08:21 AM EDT, 07/28/2025 (MT Newswires) -- Alterity Therapeutics ( ATHE ) said Monday that phase 2 data for ATH434 in patients with multiple system atrophy showed that the oral agent conferred a clinical benefit on areas of impairment in MSA and stabilized key biomarkers. Results from the trial showed that ATH434 reduced disease progression by about 50% compared with...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...